← Leaderboards
Herminia D Rosas
Massachusetts General Hospital
$18,624,312
Attributed
$18,853,937
Total exposure
17
Grants
14
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $2.2M · FY2005–25$2.5M$1.9M$1.3M$625K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$18,853,937 · 17
By mechanism
R01$15,878,945 · 3
R21$1,405,825 · 3
R56$869,751 · 1
K08$373,653 · 1
P01$217,511 · 1
M01$108,252 · 8
Top collaborators
- Julie C. Price2 shared
Most similar at Massachusetts General Hospital
Same institution · by research overlap
- Steven M Greenberg$39,743,346
- Marilyn S Albert$65,374,594
- Paul L. Huang$8,310,422
- Jane M Murphy$2,094,409
- Michael J Whalen$16,701,509
Others in their field
Top investigators on “Neurodegenerative Disorders”
- Adam L Boxer · Mayo Clinic Rochester$61,054,677
- Paul S. Aisen · Cognition Therapeutics, Inc.$56,063,985
- Ronald C Petersen · Mayo Clinic Coll Of Medicine, Rochester$55,774,157
- Reisa A. Sperling · Banner Health$50,784,577
- Jane S Paulsen · University Of Wisconsin-Madison$38,012,377
- John Q. Trojanowski · University Of Pennsylvania$37,152,274
Research focus
Neurodegenerative DisordersHuntington DiseaseImageNeuroimagingBrainImpaired CognitionCerebral AtrophyMagnetic Resonance ImagingClinical TrialsBaseGenesPathogenesisMotorModificationScanningCognitiveCohortDisease ProgressionPathway InteractionsSignal TransductionFundingMutantGeneticActivities Of Daily Living
Grant awards (38)
Understanding the Contribution of Altered Cerebrovascular Function to the Pathology and Clinical Symptoms of Huntington Disease$660,887
R01 · FY2025 · NS · contact PI
Imaging of Mitochondial Complex I function in Down Syndrome$208,750
R21 · FY2025 · AG
Imaging of Mitochondial Complex I function in Down Syndrome$250,500
R21 · FY2024 · AG
Understanding the Contribution of Altered Cerebrovascular Function to the Pathology and Clinical Symptoms of Huntington Disease$668,509
R01 · FY2023 · NS · contact PI
Huntington's Disease: Learning from Extremes$1,516,680
R01 · FY2022 · NS · contact PI
Understanding the contribution of altered cerebrovascular function to the pathology and clinical symptoms of Huntington disease$668,509
R01 · FY2022 · NS · contact PI
Huntington's Disease: Learning from Extremes$1,516,680
R01 · FY2021 · NS · contact PI
Understanding the contribution of altered cerebrovascular function to the pathology and clinical symptoms of Huntington disease$683,656
R01 · FY2021 · NS · contact PI
Huntington's Disease: Learning from Extremes$1,516,680
R01 · FY2020 · NS · contact PI
Huntington's Disease: Learning from Extremes$1,516,680
R01 · FY2019 · NS · contact PI
Huntington's Disease: Learning from Extremes$1,533,398
R01 · FY2018 · NS · contact PI
Using PET to Map Epigenetic Changes in Huntington's Disease.$213,750
R21 · FY2018 · NS · contact PI
Using PET to Map Epigenetic Changes in Huntington's Disease.$256,500
R21 · FY2017 · NS · contact PI
Prospective Neuroimaging in Huntington's Disease$869,751
R56 · FY2014 · NS · contact PI
Using High Field MRI to Evaluate Metal Dyshomeostasis in Huntington???s Disease$215,325
R21 · FY2014 · NS · contact PI
Prospective Neuroimaging in Huntington's Disease$707,015
R01 · FY2013 · NS · contact PI
Using High Field MRI to Evaluate Metal Dyshomeostasis in Huntington???s Disease$261,000
R21 · FY2013 · NS · contact PI
Prospective Neuroimaging in Huntington's Disease$723,903
R01 · FY2012 · NS · contact PI
Prospective Neuroimaging in Huntington's Disease$724,912
R01 · FY2011 · NS · contact PI
Prospective Neuroimaging in Huntington's Disease$717,715
R01 · FY2010 · NS · contact PI
Prospective Neuroimaging in Huntington's Disease$724,564
R01 · FY2009 · NS · contact PI
Neuroimaging Biomarkers for disease-modyfying therapies in Hintington's disease$217,511
P01 · FY2008 · NS · contact PI
CLINICAL TRIAL: CREST-X$2,752
M01 · FY2008 · RR · contact PI
Prospective Neuroimaging in Huntington's Disease$389,584
R01 · FY2007 · NS · contact PI
OPEN-LABEL FOLLOW-UP STUDY OF PHENYLBUTYRATE IN HD$13,823
M01 · FY2007 · RR · contact PI
CREST-X$7,394
M01 · FY2007 · RR · contact PI
NOVEL BIOMARKERS IN HUNTINGTON'S DISEASE$321
M01 · FY2007 · RR · contact PI
Prospective Neuroimaging in Huntington's Disease$401,220
R01 · FY2006 · NS · contact PI
CREST-UP1$35,321
M01 · FY2006 · RR · contact PI
OPEN-LABEL FOLLOW-UP STUDY OF PHENYLBUTYRATE IN HD$23,410
M01 · FY2006 · RR · contact PI
CREST-X$12,321
M01 · FY2006 · RR · contact PI
Prospective Neuroimaging in Huntington's Disease$410,875
R01 · FY2005 · NS
CREST-UP1$12,910
M01 · FY2005 · RR
Prospective Neuroimaging in Huntington's Disease$410,875
R01 · FY2004 · NS
Prospective Neuroimaging in Huntington's Disease$386,603
R01 · FY2003 · NS
Huntington's Disease:Morphometry, Chemistry &Cognition$129,951
K08 · FY2002 · NS
Huntington's Disease:Morphometry, Chemistry &Cognition$129,951
K08 · FY2001 · NS
HUNTINGTONS DISEASE--MORPHOMETRY, CHEMISTRY &COGNITION$113,751
K08 · FY2000 · NS